A carregar...
Characterizing expanded access and compassionate use programs for experimental drugs
OBJECTIVE: We sought to determine the characteristics of “expanded access” and “compassionate use” programs registered in ClinicalTrials.gov and to determine the percentage of drugs provided through these programs that ultimately received FDA marketing approval. RESULTS: We identified 398 expanded a...
Na minha lista:
| Publicado no: | BMC Res Notes |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5534121/ https://ncbi.nlm.nih.gov/pubmed/28754150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-017-2687-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|